BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31353258)

  • 1. Hepatitis E vaccine in China: Public health professional perspectives on vaccine promotion and strategies for control.
    Chen XX; Wagner AL; Zheng XB; Xie JY; Boulton ML; Chen KY; Ren H; Lu YH
    Vaccine; 2019 Oct; 37(43):6566-6572. PubMed ID: 31353258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Do Experts and Nonexperts Want to Promote Vaccines? Hepatitis E Vaccine as Example.
    Ren H; Wagner AL; Xie JY; Chen KY; Lu YH; Zheng XB; Huang T; Boulton ML; Chen XX
    Health Serv Insights; 2019; 12():1178632919897276. PubMed ID: 31908473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trust collapse caused by the Changsheng vaccine crisis in China.
    Zhou M; Qu S; Zhao L; Kong N; Campy KS; Wang S
    Vaccine; 2019 Jun; 37(26):3419-3425. PubMed ID: 31097351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Children's Vaccine Initiative and vaccine supply: the role of the public sector.
    van Noort RB
    Vaccine; 1992; 10(13):909-10. PubMed ID: 1471410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunization coverage of children aged 0 to 5 years in Libreville (Gabon)].
    Ategbo S; Ngoungou EB; Koko J; Vierin Y; Zang Ndong CE; Moussavou Mouyama A
    Sante; 2010; 20(4):215-9. PubMed ID: 21266317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the 2016 influenza vaccination in pregnancy campaign in NSW, Australia.
    Carlson S; Dey A; Beard F
    Public Health Res Pract; 2020 Mar; 30(1):. PubMed ID: 32152616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of South Africa's public-private partnership for the localisation of vaccine research, manufacture and distribution.
    Walwyn DR; Nkolele AT
    Health Res Policy Syst; 2018 Mar; 16(1):30. PubMed ID: 29587777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of new hepatitis E vaccines.
    Cao Y; Bing Z; Guan S; Zhang Z; Wang X
    Hum Vaccin Immunother; 2018; 14(9):2254-2262. PubMed ID: 29708836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese biotech partnership brings first hepatitis E vaccine to the market.
    Riedmann EM
    Hum Vaccin Immunother; 2012 Dec; 8(12):1743-4. PubMed ID: 23980266
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis E virus: Current epidemiology and vaccine.
    Wu X; Chen P; Lin H; Hao X; Liang Z
    Hum Vaccin Immunother; 2016 Oct; 12(10):2603-2610. PubMed ID: 27184971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial.
    Zhu FC; Zhang J; Zhang XF; Zhou C; Wang ZZ; Huang SJ; Wang H; Yang CL; Jiang HM; Cai JP; Wang YJ; Ai X; Hu YM; Tang Q; Yao X; Yan Q; Xian YL; Wu T; Li YM; Miao J; Ng MH; Shih JW; Xia NS
    Lancet; 2010 Sep; 376(9744):895-902. PubMed ID: 20728932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Influencing User Engagement of Health Information Disseminated by Chinese Provincial Centers for Disease Control and Prevention on WeChat: Observational Study.
    Zhang Y; Xia T; Huang L; Yin M; Sun M; Huang J; Ni Y; Ni J
    JMIR Mhealth Uhealth; 2019 Jun; 7(6):e12245. PubMed ID: 31250833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the private sector in vaccination service delivery in India: evidence from private-sector vaccine sales data, 2009-12.
    Sharma A; Kaplan WA; Chokshi M; Zodpey SP
    Health Policy Plan; 2016 Sep; 31(7):884-96. PubMed ID: 26976803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge, attitudes, and beliefs of school nurses and personnel and associations with nonmedical immunization exemptions.
    Salmon DA; Moulton LH; Omer SB; Chace LM; Klassen A; Talebian P; Halsey NA
    Pediatrics; 2004 Jun; 113(6):e552-9. PubMed ID: 15173536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in hepatitis immunization (A, B, E): public health policy and novel vaccine delivery.
    Hendrickx G; Vorsters A; Van Damme P
    Curr Opin Infect Dis; 2012 Oct; 25(5):578-83. PubMed ID: 22907280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Has the public lost confidence in vaccines because of a vaccine scandal in China.
    Han B; Wang S; Wan Y; Liu J; Zhao T; Cui J; Zhuang H; Cui F
    Vaccine; 2019 Aug; 37(36):5270-5275. PubMed ID: 31345640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insufficient awareness and vaccination practices for inflammatory bowel disease patients in China: A multi-center survey of Chinese gastroenterologists.
    Li SY; Li PW; Shen B; Zhi M; Gu YB; Wang XY; Guo H; Li Y; Fan YH; Yang BL; Xue M; Wang XY; Lv MF; Li Y; Ye B; Zhu XJ; Chen Y
    J Dig Dis; 2020 Jan; 21(1):46-51. PubMed ID: 31794121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis E vaccines: progress and prospects.
    Worm HC; Wirnsberger G
    Drugs; 2004; 64(14):1517-31. PubMed ID: 15233590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of private sector Hib vaccine coverage for the introduction of public sector Hib-containing pentavalent vaccine in India: evidence from retrospective time series data.
    Sharma A; Kaplan WA; Chokshi M; Hasan Farooqui H; Zodpey SP
    BMJ Open; 2015 Feb; 5(2):e007038. PubMed ID: 25712822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.